Toxins like MPP+ and rotenone, which inhibit Complex I, cause a buildup of ROS, reinforcing the connection between ETC dysfunction and disease progression in PD
It provides a compelling option for patients who may need an extra edgethose struggling with fatigue, seeking to optimize their body composition, or needing enhanced metabolic support
Phase 2 data published in the New England Journal of Medicine (2023) demonstrated substantial weight loss in adults with obesity, but the medicine is not yet approved for clinical use in the UK
Other sources (company news, FDA press releases, etc.) may be used to learn about some label changes
For instance, an increase in RO level is closely related to neuronal apoptosis, which impinges on the function and health of the nervous system, underscoring the need for further mechanistic studies [68]